Antibody Solutions for Neurotransmission, Receptor & Transporter Research

Advance your research projects to the next stage

Contact A Specialist

From Synaptic Communication to Neural Circuit Function — Empowering Comprehensive Neurotransmission Profiling with Validated Antibody Solutions

Neurotransmission is the fundamental molecular process that enables neuronal communication, information processing, behavior regulation, and maintenance of brain homeostasis. Precise coordination of neurotransmitter synthesis, vesicular storage, synaptic release, receptor activation, and signal termination ensures dynamic regulation of neuronal networks and adaptive responses to environmental stimuli.

Beyond neurotransmitter release itself, neural communication relies on highly organized molecular systems involving:

  • Neurotransmitter synthesis enzymes controlling chemical messenger production

  • Transporter systems regulating neurotransmitter uptake, recycling, and clearance

  • Vesicular machinery mediating neurotransmitter packaging and release

  • Ionotropic receptors driving rapid synaptic excitation and inhibition

  • G protein-coupled receptors (GPCRs) regulating neuromodulatory signaling

  • Intracellular signaling pathways controlling neuronal adaptation and plasticity

  • Synaptic remodeling mechanisms underlying learning, memory, and neurological function

We provide comprehensive antibody solutions for investigating neurotransmission biology—from neurotransmitter metabolism and transporter regulation to receptor signaling, synaptic organization, neural circuit modulation, and disease-associated mechanisms.

Validated antibody solutions enable researchers to characterize:

  • Neurotransmitter synthesis and metabolic pathways

  • Transporter-mediated neurotransmitter recycling mechanisms

  • Presynaptic vesicle dynamics and synaptic release machinery

  • Excitatory and inhibitory neurotransmission balance

  • Receptor localization, activation, and downstream signaling

  • Synaptic plasticity and neuronal adaptation

  • Molecular mechanisms underlying neurological and psychiatric disorders

 

Neurotransmission & Receptor Transporter Biomarker Antibody Portfolio

——Comprehensive Solutions for Neurochemical Signaling, Synaptic Communication, and Neural Circuit Research

Neuronal communication depends on precisely coordinated interactions between neurotransmitter metabolism, transporter regulation, vesicular trafficking, receptor activation, and intracellular signaling pathways.Our validated antibody portfolio targets key molecular components involved in:

Research Focus

Representative Biomarkers

Research Applications

Neurotransmitter Synthesis & Metabolism

TH, TPH2, ChAT, GAD65/GAD67, MAOA, COMT

Analysis of dopamine, serotonin, acetylcholine, and GABA synthesis pathways

Neurotransmitter Transporter Systems

DAT/SLC6A3, NET/SLC6A2, SERT/SLC6A4, GAT1/SLC6A1, GlyT1/SLC6A9

Investigation of neurotransmitter uptake, recycling, and synaptic clearance

Vesicular Neurotransmitter Packaging

VMAT2/SLC18A2, VAChT/SLC18A3, VGLUT1-3/SLC17A7-9

Characterization of neurotransmitter storage, vesicle loading, and presynaptic function

Synaptic Vesicle Release Machinery

Synaptophysin, Synapsin I, SNAP25, STX1A, VAMP2

Analysis of synaptic vesicle trafficking and neurotransmitter release

Dopaminergic Signaling Network

TH, DAT, VMAT2, DRD1-DRD5, DARPP-32

Investigation of reward circuitry, motor control, addiction, and Parkinson’s disease mechanisms

Serotonergic Signaling Network

TPH2, SERT, HTR1A, HTR2A, HTR7

Study of mood regulation, stress responses, and antidepressant mechanisms

Adrenergic Signaling Pathway

NET, ADRA1A, ADRA2A, ADRB1, ADRB2

Analysis of norepinephrine-mediated neuronal adaptation and stress signaling

GABAergic Transmission

GAD65/GAD67, GABRA1 / GABRB2 / GABRG2, GABBR1 / GABBR2 Gephyrin

Investigation of inhibitory neurotransmission, neuronal excitability, and epilepsy mechanisms

Glutamatergic Transmission

VGLUT1/2, GRIN1/GRIN2A/GRIN2B, GRIA1/GRIA2, mGluR1/5, PSD95 / DLG4. Homer1

Analysis of excitatory signaling, synaptic plasticity, learning, and memory

Cholinergic Signaling

ChAT, VAChT, CHRM1-5, CHRNA4,CHRNA7,CHRNB2

Characterization of cognition, cortical signaling, and neurodegenerative mechanisms

Presynaptic Vesicle Trafficking & Neurotransmitter Release

SYP/Synaptophysin, SYN1/Synapsin I, SV2A, SNAP25, STX1A, VAMP2, SYT1, RIMS1/2, CPLX1/2

Characterization of synaptic vesicle trafficking, docking, priming, Ca²⁺-dependent vesicle fusion, and neurotransmitter release

 

 

Neurotransmitter Receptor Signaling Network

—Comprehensive Antibody Solutions for Profiling Synaptic Communication, Neuronal Excitability, and Neural Circuit Regulation

Neurotransmitter receptors represent the molecular interface between extracellular chemical signals and neuronal responses. Through coordinated regulation of ion channels, GPCR signaling cascades, and synaptic remodeling pathways, receptor systems determine neuronal excitability, network activity, and adaptive plasticity.

Our validated receptor antibody panels enable comprehensive analysis of:

  • Fast excitatory and inhibitory synaptic transmission

  • Neuromodulatory receptor signaling

  • Synaptic plasticity mechanisms

  • Neuronal adaptation and circuit remodeling

  • Disease-associated receptor dysfunction

Research Focus

Key Markers

Research Applications

Glutamatergic Receptor Signaling

NMDA receptors (GRIN1, GRIN2A, GRIN2B), AMPA receptors (GRIA1, GRIA2), mGluR1, mGluR5, Kainate receptors

Investigation of excitatory transmission, learning, memory formation, synaptic plasticity, and excitotoxicity

GABAergic Receptor Signaling

GABA-A receptor subunits, GABA-B receptors, Gephyrin, GAD65/GAD67

Analysis of inhibitory circuits, excitation–inhibition balance, epilepsy, and neural network stability

Glycinergic Signaling

GlyT1 / SLC6A9,GlyT2 / SLC6A5,GLRA1,GLRA2,GLRB, Gephyrin

 

Dopaminergic Receptor Signaling

DRD1-DRD5, TH, DAT, VMAT2, DARPP-32, CREB / p-CREB

Characterization of reward pathways, movement regulation, addiction, and Parkinson’s disease

Serotonergic Receptor Signaling

HTR1A, HTR2A, HTR2C, HTR3A, HTR7

Study of emotional regulation, psychiatric disorders, and antidepressant responses

Adrenergic Receptor Signaling

ADRA1, ADRA2, ADRB1, ADRB2, CREB, ERK/MAPK pathway markers

Investigation of stress adaptation, autonomic regulation, and neuronal signaling responses

Cholinergic Receptor Signaling

CHRM1-5, ChAT, VAChT, CHRNA4, CHRNA7, CHRNB2

Research on cognition, memory, aging, and Alzheimer’s disease mechanisms

Opioid Receptor Signaling

MOR/OPRM1, DOR/OPRD1, KOR/OPRK1

Investigation of pain processing, reward circuits, addiction, and neural adaptation

 

Featured Neurotransmission Research Panels

—Integrated Antibody Panels for Synaptic Function, Neural Circuit Mapping, and Disease Mechanism Discovery

Our comprehensive antibody panels enable researchers to systematically profile neurotransmission-associated pathways—from presynaptic neurotransmitter handling to postsynaptic signal integration, providing powerful tools for investigating neuronal function, synaptic plasticity, and neurological disease mechanisms.

n  Neurotransmitter Synthesis & Homeostasis Panel—Profiling neurotransmitter production, metabolic regulation, and synaptic chemical homeostasis

TH

TPH2

ChAT

GAD65

GAD67

AADC

MAOA

COMT

n  Neurotransmitter Transport & Clearance Panel—Characterizing reuptake, extracellular clearance, and neuron–glia neurotransmitter homeostasis

DAT/SLC6A3

NET/SLC6A2

SERT/SLC6A4

GAT1/SLC6A1

GAT3/SLC6A11

GlyT1/SLC6A9

EAAT1/SLC1A3

EAAT2/SLC1A2

n  Vesicular Loading & Presynaptic Release Panel—Mapping neurotransmitter packaging, vesicle trafficking, Ca²⁺-dependent release, and synaptic vesicle cycling

VMAT2/SLC18A2

VAChT

VGLUT1/2

Synaptophysin

SV2A

Synapsin I

SNAP25

VAMP2

STX1A

SYT1

 

n  Excitatory–Inhibitory Synaptic Signaling Panel—Profiling glutamatergic and GABAergic receptor systems underlying neuronal excitability and synaptic plasticity

GRIN1

GRIN2A

GRIN2B

GRIA1/2

GRM1

GRM5

GABRA1

GABRB2

GABRG2

GABBR1

GABBR2

Gephyrin

n  Synaptic Architecture & Plasticity Panel——Connecting neurotransmission with synaptic organization, activity-dependent signaling, and neuronal adaptation

PSD95

Homer1

Synaptophysin

Synapsin I

MAP2

CaMKII

CREB

p-CREB

BDNF

NeuN

 

Why Researchers Choose Our Neurotransmission & Receptor Transporter Antibody Solutions

Validated Neural Targets. Integrated Synaptic Pathway Coverage. Mechanism-Driven Neuroscience Research.

Our validated antibody portfolio supports researchers in connecting neurotransmitter synthesis, transport, vesicular release, receptor activation, synaptic organization, and downstream signaling within an integrated experimental framework.

Research Challenge

Our Solution

How can I characterize neurotransmitter synthesis and homeostasis?

TH, TPH2, ChAT, GAD65/GAD67 and neurotransmitter metabolism markers

How can I analyze neurotransmitter uptake and clearance?

DAT, NET, SERT, GAT, GlyT and EAAT transporter solutions

How can I investigate vesicular neurotransmitter loading?

VMAT2, VAChT and VGLUT1/2/3 vesicular transporter antibodies

How can I characterize presynaptic neurotransmitter release?

Synaptophysin, SV2A, SNAP25, VAMP2, STX1A and SYT1

How can I profile excitatory and inhibitory neurotransmission?

NMDA, AMPA, mGluR, GABA-A/GABA-B and Gephyrin panels

How can I investigate neuromodulatory signaling?

Dopamine, serotonin, adrenergic, cholinergic and opioid receptor solutions

How can I study synaptic plasticity?

PSD95, Homer1, CaMKII, CREB/p-CREB and BDNF signaling markers

How can I map neurotransmission in neural tissues?

IF/IHC and multiplex-compatible neuronal, synaptic, receptor and transporter antibodies

How can I connect molecular changes with neurological disease mechanisms?

Integrated neurotransmitter, receptor, transporter and synaptic architecture panels


 

Key reference

1. Shabareesh Pidathala, Shuyun Liao (2023). Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2. Nature. 2023 Nov;623(7989):1086-1092.

2. Tingyan Wu, Weili Cai (2023). Epigenetic regulation of neurotransmitter signaling in neurological disorders. Neurobiol Dis. 2023 Aug:184:106232.

3. Jiaxin Tan, Yuan Xiao (2024). Molecular basis of human noradrenaline transporter reuptake and inhibition. Nature. 2024 Aug;632(8026):921-929.

4. Heng Zhang, Yu-Ling Yin (2024). Dimerization and antidepressant recognition at noradrenaline transporter. Nature. 2024 Jun;630(8015):247-254.

5. Qiao Ma, Kunpeng Ma (2025). Binding mechanism and antagonism of the vesicular acetylcholine transporter VAChT. Nat Struct Mol Biol. 2025 May;32(5):818-827.

6. Changping Zhou, Guadalupe Segura-Covarrubias (2026). Cryo-EM structures of apo, agonist- and antagonist-bound heteromeric kainate receptors. Sci Adv. 2026 Jul 31;12(31):eady7558.

REQUEST A QUOTE

Reach our technical and product support team through your preferred channel.

EMAIL

info@mail.ucallm.com

PHONE

+(1)-866-986-9598

ONLINE FORM

Online Quote Submission

FAX

+(1)-866-986-9598